Gangneung-si, Gangwon-do, South Korea | Fund Name | Location |
| AngelHub | China, Hong Kong, Hong Kong Island |
| Ariba | California, Sunnyvale, United States |
| Estlander & Partners | - |
| Fengji Touzi | China, Guangdong Province, Huizhou |
| FinRise | - |
| Hengqinhexiang Venture | China, Guangdong, Zhuhai |
| iVision Ventures | Beijing, Beijing, China |
| Jiaxing Yuanqi Investment | China, Jiaxing, Zhejiang |
| Lang & Schwarz | Düsseldorf, Germany, Nordrhein-Westfalen |
| MulticoreWare | California, Saratoga, United States |
| Panxi Capital Management | - |
| Pilgrim, Baxter & Associates | - |
| Qiu Zhang Dian Zi | China, Shanghai |
| RFT Investment Company | Atlanta, Georgia, United States |
| Riot Ventures | California, Los Angeles, United States |
| Shanghai Jingzhi Enterprise Management | China, Shanghai |
| Skyfall Ventures | Norway, Oslo |
| Wosheng Cci Capital | China, Guangxi, Jiangsu |
| Zhongxing Hongtai Touzi | China, Shaanxi, Xian Shi |
| Zibo Qixin | China, Qingdao Shi, Shandong |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Rodwin | $15M | 09 May 2022 | Seoul, Seoul-t'ukpyolsi, South Korea | ||
BIORCHESTRA | $47M | 22 Feb 2022 | South Korea, Gangwon-do, South Korea | ||
iMediSync | $6M | 27 Jan 2022 | Yeoksamdong, Seoul-t'ukpyolsi, South Korea | ||
Rodwin | $3M | 01 Jul 2021 | Seoul, Seoul-t'ukpyolsi, South Korea | ||
Newracle Genetics | $26M | 03 Jun 2021 | Seoul, Seoul-t'ukpyolsi, South Korea | ||
ProAbTech | $4M | 10 Aug 2020 | South Korea, Gangwon-do, South Korea | ||
SN BioScience | $609K | 02 Jul 2020 | Seoul, Seoul-t'ukpyolsi, South Korea | ||
Novelty Nobility | $8M | 04 Feb 2020 | Seongnam, Kyonggi-do, South Korea |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Rodwin | $15M | 09 May 2022 | Seoul, Seoul-t'ukpyolsi, South Korea | ||
BIORCHESTRA | $47M | 22 Feb 2022 | South Korea, Gangwon-do, South Korea | ||
iMediSync | $6M | 27 Jan 2022 | Yeoksamdong, Seoul-t'ukpyolsi, South Korea | ||
Rodwin | $3M | 01 Jul 2021 | Seoul, Seoul-t'ukpyolsi, South Korea | ||
Newracle Genetics | $26M | 03 Jun 2021 | Seoul, Seoul-t'ukpyolsi, South Korea | ||
ProAbTech | $4M | 10 Aug 2020 | South Korea, Gangwon-do, South Korea | ||
SN BioScience | $609K | 02 Jul 2020 | Seoul, Seoul-t'ukpyolsi, South Korea | ||
Novelty Nobility | $8M | 04 Feb 2020 | Seongnam, Kyonggi-do, South Korea |
